PCV89 Cost-Effectiveness Analysis of Rosuvastatin Versus Generic Atorvastatin in Patients at High Cardiovascular Risk in Spain
Abstract
Authors
M. Brosa V. Barrios J.M. Lobos A. Serrano M. Capel C. Alvarez
M. Brosa V. Barrios J.M. Lobos A. Serrano M. Capel C. Alvarez
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now